AbbVie (ABBV), Allergan (AGN) Merger Cleared by FTC
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/25/2026
- Wall St edges up as AI enthusiasm eases worries over higher oil prices, yields
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices ease as US-Iran truce hopes counter Saudi supply risk
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- Akamai signs $11.6B deal with Anthropic, up to $20B potential
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- US and Iran discuss phased deal to reopen Hormuz and end US blockade, sources say
Mizuho Securities Reiterates Buy Rating on Abbvie (ABBV) Following US FTC Clearance Announcement
May 6, 2020 7:07 AM EDTMizuho Securities analyst Vamil Divan reiterated a Buy rating and $101.00 price target on Abbvie (NYSE: ABBV) following the company's announcement that they have received US FTC clearance for the Allergan deal. ABBV plans to close the deal this month.
A key concern... More
